Science News & Science Current Events
 

Angiogenesis Cancer Current Events | Angiogenesis Cancer News | 3
Page 3 of 96 | 2394 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
New animal study may explain why alcohol consumption increases breast cancer risk
For the first time, scientists have used a laboratory mouse model to mimic the development of human alcohol-induced breast cancer.   view more (2007-04-30)

New study shows way to avoid overtreatment in breast cancer
The numbers of women who receive adjuvant chemotherapy for breast cancer could be reduced by 30 to 40% if the results of a new molecular study are put into practice. Dr Laura van 't Veer from the Netherlands Cancer Institute told the news briefing that micro array technology* can help predict which... view more (2002-03-20)

Study first: Over-expression of Cox-2 can predict prostate cancer outcome
Researchers say an over-expression of COX-2 in men with prostate cancer is associated with an increase in PSA after radiation treatment and the spread of the cancer outside of the prostate.   view more (2006-11-09)

Cancer stem cells: know thine enemy
Stem cells -- popularly known as a source of biological rejuvenation -- may play harmful roles in the body, specifically in the growth and spread of cancer.   view more (2007-12-26)

Novel findings about neovessel formation
The main role in new findings about neovessel formation is played by a protein called tissue factor. This factor turns out to have both a stimulatory function and an inhibitory function in the generation of blood vessels. Normally these two functions neutralize each other, but in diseases like... view more (2004-05-10)

Cancer drug can extend survival in patients with deadly brain tumors
Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.   view more (2007-02-20)

Drug fends off kidney cancer progression
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.   view more (2008-05-19)

VEGF Trap shows activity in patients with advanced ovarian cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.   view more (2007-06-04)

Researchers announce new predictor for lung cancer treatment and survival
Research from the Ireland Cancer Center of University Hospitals of Cleveland has found a promising, novel biomarker that may be used to predict the survival of patients with advanced lung cancer and their response to treatment.   view more (2006-06-06)

Ancient Chinese remedy shows potential in preventing breast cancer
A derivative of the sweet wormwood plant used since ancient times to fight malaria and shown to precisely target and kill cancer cells may someday aid in stopping breast cancer before it gets a toehold.   view more (2005-12-20)

Enzyme eliminated by cancer cells holds promise for cancer treatment
An enzyme that cancer cells eliminate, apparently so they can keep proliferating, may hold clues to more targeted, effective cancer treatment, scientists say.   view more (2007-07-19)

CSHL scientists successfully target tumor microenvironment to stop cancer growth
Cold Spring Harbor Laboratory (CSHL) researchers led by Daniel Nolan and Assistant Professor Vivek Mittal have found that bone marrow (BM) derived endothelial progenitor cells (EPCs) play a critical role in the early stages of tumor progression and that eliminating EPCs stops cancer growth.   view more (2007-06-18)

First report that apoptotic and anti-angiogenic therapies work better together than alone
American researchers have found that giving a combination of imantanib (Glivec) and a drug that induces cell death (apoptosis) was better at inhibiting the growth of Ewing's sarcoma in mice than either therapy on its own.   view more (2006-11-13)

Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy
While new blood vessel growth from preexisting capillaries ("angiogenesis") is fundamental to survival, the abnormal formation of new blood vessels ("neovascularization") contributes to the pathogenesis of tumor growth and metastasis as well as the vast majority of diseases that... view more (2007-01-11)

Taxol with avastin produces noteworthy results
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.   view more (2007-12-28)

Bevacizumab found to improve survival for patients with advanced breast cancer
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.   view more (2007-12-27)

Blood pressure drugs associated with reduced risk of esophageal, pancreatic and colon cancers
Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension.   view more (2006-05-24)

Novel Discoveries Leading To Targeted Treatment Of Lymphatic Diseases
A gene responsible for lymphatic vessel formation Novel discoveries at the University of Helsinki, Finland, about the development of the lymphatic network may help researchers to better understand the mechanisms of cancer and its metastasis, and also diseases such as lymphedema, wound healing and... view more (2003-11-20)

Scientists Uncover Mechanism of Response to Targeted Therapy in Kidney Cancer
UCLA researchers knew-based on two clinical trials-that a subset of kidney cancer patients responded well to an experimental targeted therapy, but they didn't know why.   view more (2006-01-13)

Rescuing injured hearts by enhancing regeneration
Using a two-drug approach, researchers at Children's Hospital Boston have demonstrated that it may be possible to rescue heart function after a heart attack and protect the heart from scarring.   view more (2006-10-10)

Fruits, vegetables and teas may protect smokers from lung cancer, UCLA researchers report
Tobacco smokers who eat three servings of fruits and vegetables per day and drink green or black tea may be protecting themselves from lung cancer, according to a first-of-its-kind study by UCLA cancer researchers.   view more (2008-05-29)

Study broadens understanding of enzymes linked to tumor promoting molecule
Virginia Commonwealth University Massey Cancer Center researchers have found that two enzymes that catalyze the same reaction and produce the same product have opposite effects on cell growth and death.   view more (2005-11-07)

Systemic treatment before surgery for kidney cancer prolongs patients' survival
Preliminary results from a phase II clinical trial have provided the first evidence that treating people with kidney cancer with bevacizumab and erlotinib before surgery is safe, effective and may prolong patients' survival.   view more (2006-11-09)

Doctors conclude temsirolimus is effective new treatment for advanced renal cell carcinoma
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.   view more (2007-05-31)

COX-2 Inhibitors Significantly Reduce Risk of Cancer
Results from a new, five-year study show that regular use of popular prescription pain relievers may reduce the risk of breast cancer by up to 71 percent and may offer similar benefit in the prevention of prostate, colon and lung cancers.   view more (2006-04-04)
Page 3 of 96 | 2394 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com